These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23352054)

  • 1. The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.
    Howard J; Malfroy M; Llewelyn C; Choo L; Hodge R; Johnson T; Purohit S; Rees DC; Tillyer L; Walker I; Fijnvandraat K; Kirby-Allen M; Spackman E; Davies SC; Williamson LM
    Lancet; 2013 Mar; 381(9870):930-8. PubMed ID: 23352054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative transfusion in patients with sickle-cell disease.
    Goldsmith JC; Wang WC
    Lancet; 2013 Mar; 381(9870):886-8. PubMed ID: 23352053
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
    Vichinsky EP; Haberkern CM; Neumayr L; Earles AN; Black D; Koshy M; Pegelow C; Abboud M; Ohene-Frempong K; Iyer RV
    N Engl J Med; 1995 Jul; 333(4):206-13. PubMed ID: 7791837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
    Wang WC; Ware RE; Miller ST; Iyer RV; Casella JF; Minniti CP; Rana S; Thornburg CD; Rogers ZR; Kalpatthi RV; Barredo JC; Brown RC; Sarnaik SA; Howard TH; Wynn LW; Kutlar A; Armstrong FD; Files BA; Goldsmith JC; Waclawiw MA; Huang X; Thompson BW;
    Lancet; 2011 May; 377(9778):1663-72. PubMed ID: 21571150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study].
    Ould amar AK; Delattre O; Godbille C; Béra O; Halbout PA; Catonné Y
    Transfus Clin Biol; 2003 Apr; 10(2):61-6. PubMed ID: 12763144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
    Howard J; Ataga KI; Brown RC; Achebe M; Nduba V; El-Beshlawy A; Hassab H; Agodoa I; Tonda M; Gray S; Lehrer-Graiwer J; Vichinsky E
    Lancet Haematol; 2021 May; 8(5):e323-e333. PubMed ID: 33838113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases.
    Koshy M; Weiner SJ; Miller ST; Sleeper LA; Vichinsky E; Brown AK; Khakoo Y; Kinney TR
    Blood; 1995 Nov; 86(10):3676-84. PubMed ID: 7579333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery.
    Al-Samak ZM; Al-Falaki MM; Pasha AA
    Middle East J Anaesthesiol; 2008 Jun; 19(5):983-95. PubMed ID: 18637600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
    Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
    Dastgiri S; Dolatkhah R
    Cochrane Database Syst Rev; 2016 Aug; (8):CD007843. PubMed ID: 27574910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.
    Vichinsky EP; Neumayr LD; Haberkern C; Earles AN; Eckman J; Koshy M; Black DM
    Am J Hematol; 1999 Nov; 62(3):129-38. PubMed ID: 10539878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group.
    Waldron P; Pegelow C; Neumayr L; Haberkern C; Earles A; Wesman R; Vichinsky E
    J Pediatr Hematol Oncol; 1999; 21(2):129-35. PubMed ID: 10206459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.
    Spackman E; Sculpher M; Howard J; Malfroy M; Llewelyn C; Choo L; Hodge R; Johnson T; Rees DC; Fijnvandraat K; Kirby-Allen M; Davies S; Williamson L
    Eur J Haematol; 2014 Mar; 92(3):249-55. PubMed ID: 24329965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative blood transfusions for sickle cell disease.
    Hirst C; Williamson L
    Cochrane Database Syst Rev; 2012 Jan; 1():CD003149. PubMed ID: 22258951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial.
    Maggio A; Kattamis A; Felisi M; Reggiardo G; El-Beshlawy A; Bejaoui M; Sherief L; Christou S; Cosmi C; Della Pasqua O; Del Vecchio GC; Filosa A; Cuccia L; Hassab H; Kreka M; Origa R; Putti MC; Spino M; Telfer P; Tempesta B; Vitrano A; Tsang YC; Zaka A; Tricta F; Bonifazi D; Ceci A
    Lancet Haematol; 2020 Jun; 7(6):e469-e478. PubMed ID: 32470438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open heart surgery in patients with sickle cell hemoglobinopathy.
    Yousafzai SM; Ugurlucan M; Al Radhwan OA; Al Otaibi AL; Canver CC
    Circulation; 2010 Jan; 121(1):14-9. PubMed ID: 20026775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative blood transfusions for sickle cell disease.
    Riddington C; Williamson L
    Cochrane Database Syst Rev; 2001; (3):CD003149. PubMed ID: 11687042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for complications after abdominal surgery in children with sickle cell disease.
    Snyder CW; Bludevich BM; Gonzalez R; Danielson PD; Chandler NM
    J Pediatr Surg; 2021 Apr; 56(4):711-716. PubMed ID: 33010885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.